Company intelligence
ElevateBio
About ElevateBio
ElevateBio is a technology-driven advanced therapy contract development and manufacturing organization (CDMO) powering the creation of life-transforming therapies. The company helps biopharmaceutical partners design, develop, and manufacture therapies from early discovery through commercialization. Combining proprietary gene editing tools and services, cGMP manufacturing capabilities, and industry-leading expertise, ElevateBio is enabling partners advance a breadth of therapeutic approaches and modalities including cell therapies, gene edited therapies, RNA therapies, mRNA vaccines, and more.
Verified activity
Signals from ElevateBio
4 published signals
Presence & Recognition
ElevateBio provided a forum for Yogesh Waghmare to share his thoughts through a blog series.
Reported by Yogesh Waghmare, PhD
People
ElevateBio has appointed Steve Falcone as Chief Operating Officer.
Reported by ElevateBio
Research & Knowledge
ElevateBio Chief Technology Officer Michael Paglia developed a 10-question framework for choosing a CDMO based on his experience leading process development and manufacturing teams.
Reported by ElevateBio
Products & Services
ElevateBio offers gene editing services optimized across 5 editing modalities to deliver efficacy, specificity, and safety.
Reported by Jeff Briganti